Relationship between PCSK9/LRP1 and lipoprotein receptor related protein 1 and lipoprotein regulation in patients with coronary heart disease with phlegm turbidity syndrome
|更新时间:2023-04-10
|
Relationship between PCSK9/LRP1 and lipoprotein receptor related protein 1 and lipoprotein regulation in patients with coronary heart disease with phlegm turbidity syndrome
Beijing Journal of Traditional Chinese MedicineVol. 40, Issue 6, Pages: 580-583(2021)
SHI Shuai, JIANG Yu-chen, JI Xin-yu. Relationship between PCSK9/LRP1 and lipoprotein receptor related protein 1 and lipoprotein regulation in patients with coronary heart disease with phlegm turbidity syndrome. [J]. Beijing Journal of Traditional Chinese Medicine 40(6):580-583(2021)
DOI:
SHI Shuai, JIANG Yu-chen, JI Xin-yu. Relationship between PCSK9/LRP1 and lipoprotein receptor related protein 1 and lipoprotein regulation in patients with coronary heart disease with phlegm turbidity syndrome. [J]. Beijing Journal of Traditional Chinese Medicine 40(6):580-583(2021) DOI: 10.16025/j.1674-1307.2021.06.005.
Relationship between PCSK9/LRP1 and lipoprotein receptor related protein 1 and lipoprotein regulation in patients with coronary heart disease with phlegm turbidity syndrome
Systemic evaluation of Shexiang Baoxin Bolus for the treatment of coronary heart disease complicated with hyperlipemia
活血温通法治疗冠心病研究进展
FENG Wei-liang’s experience in treating anxiety after coronary intervention after surgery with Shugan Huoxue Formula
Clinical efficacy of Huatan Tiaozhi Decoction in adjuvant treatment of patients with coronary heart disease accompanied with dyslipidemia and its influence on serum Hcy and blood lipid indexes
Treatment of coronary heart disease without blood circulation reconstructed with the method of nourishing yang and promoting blood circulation